Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03977454 · ClinicalTrials.gov registry record · Phase 2
Periarticular Injection Versus Peripheral Nerve Block in Total Hip Arthroplasty
A Phase 2 study, sponsored by Yale University.
- Completed
- Registry status
- Phase 2
- Development phase
- 192
- Enrollment target
NCT03977454: Completed Phase 2 study, sponsored by Yale University.
NCT03977454 is a Phase 2 study that has completed, run by Yale University. The registered enrollment target is 192 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (44% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03977454, a Phase 2 study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 192 participants
- Enrollment target
Study Summary
This study will assess if preoperative quadratus lumborum block (QLB)/lateral femoral cutaneous nerve block (LFCNB) with ropivacaine and glucocorticoids provide more effective analgesia than periarticular injection (PAI) with the same mixture in total hip arthroplasty (THA).
Primary Outcome
Daily opioid consumption will be monitored during the patient's post surgical hospitalization. Data are presented as milligram morphine equivalent (MME). When the results were entered, the time frame was corrected to reflect the final approved protocol.
Interventions
- DRUG Ropivacaine
- PROCEDURE Nerve Block
- PROCEDURE Periarticular Injection (PAI)
- DRUG Dex
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 192 participants |
| Start Date | 2019-11-11 |
| Est. Completion | 2021-06-19 |
| Phase | Phase 2 |
What the finished NCT03977454 record still lists
NCT03977454 is an interventional study that assigns participants to a tested intervention. The registered 192 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (44% higher).
The record links to 0 conditions, and to 4 interventions - of which Ropivacaine is the first listed.
NCT03977454 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03977454 about?
NCT03977454 is a clinical study titled "Periarticular Injection Versus Peripheral Nerve Block in Total Hip Arthroplasty". This study will assess if preoperative quadratus lumborum block (QLB)/lateral femoral cutaneous nerve block (LFCNB) with ropivacaine and glucocorticoids provide more effective analgesia than periarticular injection (PAI) with the same mixture in total hip arthroplasty (THA).
What is the current status of trial NCT03977454?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 192 participants. The study started on 2019-11-11. Estimated completion is 2021-06-19.
What interventions are being tested in trial NCT03977454?
The interventions under investigation include: Ropivacaine (DRUG), Nerve Block (PROCEDURE), Periarticular Injection (PAI) (PROCEDURE), Dex (DRUG).
Who is sponsoring clinical trial NCT03977454?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03977454's enrollment target sits among peer trials
192 352nd of 2000 higher than 1,648 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01492972 · 192 participants · Phase 3
Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer
- NCT01973881 · 192 participants
Quantitative MRI for Myelofibrosis
- NCT02535702 · 192 participants · NA
Development Of Neuroimaging Methods To Assess The Neurobiology Of Addiction
- NCT03622359 · 192 participants · NA
Radiotracer-Based Perfusion Imaging of Patients With Peripheral Arterial Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI